[go: up one dir, main page]

AU8774882A - Active compound of kitasamycin and quinoxaline di-n- oxides - Google Patents

Active compound of kitasamycin and quinoxaline di-n- oxides

Info

Publication number
AU8774882A
AU8774882A AU87748/82A AU8774882A AU8774882A AU 8774882 A AU8774882 A AU 8774882A AU 87748/82 A AU87748/82 A AU 87748/82A AU 8774882 A AU8774882 A AU 8774882A AU 8774882 A AU8774882 A AU 8774882A
Authority
AU
Australia
Prior art keywords
kitasamycin
oxides
active compound
hydrogen
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU87748/82A
Other versions
AU552563B2 (en
Inventor
Peter Henry SELLE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6140231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU8774882(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU8774882A publication Critical patent/AU8774882A/en
Application granted granted Critical
Publication of AU552563B2 publication Critical patent/AU552563B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

1. Active compound combination consisting of kitasamycin and 2-methyl-3-carboxamidoquinoxaline- -1,4-di-N-oxides of the general formula I see diagramm : EP0073390,P9,F2 wherein R**1 represents hydrogen, lower alkyl, lower alkoxy radicals and chlorine, R**2 represents hydrogen or a straight-chain or branched alkyl radical which is optionally substituted by a hydroxyl, lower alkoxy, carboalkoxy, mono- or dialkylamino radical, R**3 can represent hydrogen and wherein R**3 furthermore can be identical to or different from R**2 and in the case where R**2 is hydrogen R**3 can also represent the cyclohexyl radical and wherein in the case where R**2 and R**3 denote alkyl these radicals, together with the amide nitrogen atom, can be a constituent of a 5- or 6-membered heterocyclic ring system.
AU87748/82A 1981-08-27 1982-08-26 Active compound of kitasamycin and quinoxaline di-n- oxides Expired AU552563B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19813133888 DE3133888A1 (en) 1981-08-27 1981-08-27 ACTIVE COMBINATION OF KITASAMYCIN AND CHINOXALIN-DI-N-OXIDES
DE31338887 1981-08-27

Publications (2)

Publication Number Publication Date
AU8774882A true AU8774882A (en) 1983-03-03
AU552563B2 AU552563B2 (en) 1986-06-05

Family

ID=6140231

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87748/82A Expired AU552563B2 (en) 1981-08-27 1982-08-26 Active compound of kitasamycin and quinoxaline di-n- oxides

Country Status (12)

Country Link
EP (1) EP0073390B1 (en)
JP (1) JPS5852224A (en)
KR (1) KR860000275B1 (en)
AT (1) ATE20171T1 (en)
AU (1) AU552563B2 (en)
BR (1) BR8205020A (en)
DE (2) DE3133888A1 (en)
EG (1) EG15924A (en)
ES (1) ES8400014A1 (en)
FI (1) FI70364C (en)
PH (1) PH19663A (en)
ZA (1) ZA826230B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230273A1 (en) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen LIGHT-STABILIZED CHINOXALINE DI-N-OXIDES
DE3340931A1 (en) * 1983-11-11 1985-05-23 Bayer Ag, 5090 Leverkusen DUST-FREE CHINOXALIN-1,4-DI-N-OXIDE
JPH06701B2 (en) * 1983-12-01 1994-01-05 旭化成工業株式会社 Veterinary composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535309A (en) * 1967-09-01 1970-10-20 Kitasato Inst Antibiotics and their production
DE1670935C3 (en) * 1967-10-04 1975-12-04 Bayer Ag, 5090 Leverkusen 2-Methyl-3-carboxamidoquinoxaline-1,4-dl-N-oxides, a process for their preparation and antibacterial agents containing these compounds
AT281841B (en) * 1968-10-03 1970-06-10 Bayer Ag PROCESS FOR THE PRODUCTION OF NEW 2-METHYL-3-CARBONIC ACIDAMIDO-QUINOXALINDI-N-OXIDEN- (1,4)
SU890961A3 (en) * 1976-01-20 1981-12-15 Циба-Гейги Аг (Фирма) Growth stimulating agent for animals
US4254120A (en) * 1978-12-19 1981-03-03 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides

Also Published As

Publication number Publication date
EG15924A (en) 1986-12-30
FI822950A0 (en) 1982-08-25
AU552563B2 (en) 1986-06-05
EP0073390B1 (en) 1986-06-04
DE3133888A1 (en) 1983-03-10
JPS5852224A (en) 1983-03-28
KR860000275B1 (en) 1986-03-26
PH19663A (en) 1986-06-09
FI70364B (en) 1986-03-27
ES515272A0 (en) 1983-10-16
BR8205020A (en) 1983-06-07
ES8400014A1 (en) 1983-10-16
ATE20171T1 (en) 1986-06-15
FI70364C (en) 1986-09-19
ZA826230B (en) 1983-07-27
EP0073390A1 (en) 1983-03-09
FI822950L (en) 1983-02-28
DE3271554D1 (en) 1986-07-10
KR840000903A (en) 1984-03-26

Similar Documents

Publication Publication Date Title
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
NZ215008A (en) Heterocyclic compounds and herbicidal compositions
TW376382B (en) Arylcycloalkyl derivatives for against inflammatory conditions
MY102277A (en) Quinoline compounds
ES430709A1 (en) 1-(Imidazolyl-1)-2-aryloxy-3-hydroxy-alkanes
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
MY102973A (en) Isoindolinyl alkyl piperazines
ES8401067A1 (en) Treatment of migraine with tropyl benzoate derivatives.
MX9505054A (en) Bisphenol ester derivatives.
AU552563B2 (en) Active compound of kitasamycin and quinoxaline di-n- oxides
ES453881A1 (en) 1,3-dithiolo(4,5-b)pyrazin-2-ylidene-propanedinitrile 4-oxide
GR3020420T3 (en) Alkyl derivatives of trazodone with cns activity.
AU567163B2 (en) B-carbolin-3-carboxylic acid derivatives
NZ333854A (en) Intermediates for the preparation of 2-imidazoline-5-ones
MY100938A (en) Arylkylimidazole derivatives.
ES8401066A1 (en) 1,5-substituted isoquinoline derivatives.
IE780982L (en) 4-hydroxythiazoline-2-thiones.
GR77967B (en)
ES479928A1 (en) 9.9-Dimethyl-6.7-benzomorphan derivatives, processes for their preparation and pharmaceutical compositions comprising them.
ATE69819T1 (en) 1-OXA-1-DETHIA CEPHALOSPORIN COMPOUNDS AND ANTIBACTERIAL AGENT CONTAINING THEM.
GR851530B (en)
DE3460030D1 (en) Alpha-alkoxylated n-(3,3,5- or 3,5,5-trimethylcyclohexen-1-yl)-n-alkyl or n-allyl-acetamides and their use in phytotoxic preparations
MY102050A (en) Imidazole anologs of mevalonolactone and derivatives thereof
GB1512540A (en) N-haloacyl-(4-spirocycloaliphatic) oxazolidines
JPS5412390A (en) Thiadiazine and insecticide or acaricide containing the same

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired